Prematür Retinopatisinde Güncel Yaklaşım

Hellstrom A, Smith LE and Dammann O. Retinopathy of prematurity. Lancet 2013; 382:1445-1457.

Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008; 84:77-82.

Tsai AS, Chou HD, Ling XC et al. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res 2022; 88:101018.

Al-Khaled T, Valikodath NG, Patel SN et al. Addressing the Third Epidemic of Retinopathy of Prematurity Through Telemedicine and Technology: A Systematic Review. J Pediatr Ophthalmol Strabismus 2021; 58:261-269.

Hartnett ME. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 2015; 122:200-210.

Chan-Ling T, Gole GA, Quinn GE et al. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective. Prog Retin Eye Res 2018; 62:77-119.

Agarwal K and Jalali S. Classification of retinopathy of prematurity: from then till now. Community Eye Health 2018; 31:S4-S7.

Fierson WM, Ophthalmology AAOPSo, American Academy Of O et al. Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics 2018; 142.

Chen Y, Feng J, Li F et al. Analysis of Changes in Characteristics of Severe Retinopathy of Prematurity Patients after Screening Guidelines Were Issued in China. Retina 2015; 35:1674-1679.

Adeli M and Bloom WR. Implementing Telemedicine Visits in an Underserved Ophthalmology Clinic in the COVID-19 Era. J Prim Care Community Health 2021; 12:2150132721996278.

Weaver DT and Murdock TJ. Telemedicine detection of type 1 ROP in a distant neonatal intensive care unit. J AAPOS 2012; 16:229-233.

Wang SK, Callaway NF, Wallenstein MB et al. SUNDROP: six years of screening for retinopathy of prematurity with telemedicine. Can J Ophthalmol 2015; 50:101-106.

Campbell JP, Ryan MC, Lore E et al. Diagnostic Discrepancies in Retinopathy of Prematurity Classification. Ophthalmology 2016; 123:1795-1801.

Redd TK, Campbell JP, Brown JM et al. Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity. Br J Ophthalmol 2018.

Brown JM, Campbell JP, Beers A et al. Automated Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Convolutional Neural Networks. JAMA Ophthalmol 2018; 136:803-810.

Palmer EA, Hardy RJ, Dobson V et al. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 2005; 123:311-318.

Palmer EA, Flynn JT, Hardy RJ et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991; 98:1628-1640.

Hardy RJ, Good WV, Dobson V et al. Multicenter trial of early treatment for retinopathy of prematurity: study design. Control Clin Trials 2004; 25:311-325.

Good WV and Early Treatment for Retinopathy of Prematurity Cooperative G. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004; 102:233-248; discussion 248-250.

Tasman W, Patz A, McNamara JA et al. Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol 2006; 141:167-174.

Sankar MJ, Sankar J and Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev 2018; 1:CD009734.

Mintz-Hittner HA. Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes. J AAPOS 2016; 20:478-480.

Mintz-Hittner HA, Kennedy KA, Chuang AZ et al. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 364:603-615.

Stahl A, Lepore D, Fielder A et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet 2019; 394:1551-1559.

Kaushal M, Razak A, Patel W et al. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol 2021; 41:1225-1235.

Xu Y, Zhang Q, Kang X et al. Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection. Acta Ophthalmol 2013; 91:e304-310.

Nudleman E, Muftuoglu IK, Gaber R et al. Glaucoma after Lens-Sparing Vitrectomy for Advanced Retinopathy of Prematurity. Ophthalmology 2018; 125:671-675.

Nudleman E, Robinson J, Rao P et al. Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity. Ophthalmology 2015; 122:755-759.

Nelson LB. Telemedicine in Pediatric Ophthalmology. J Pediatr Ophthalmol Strabismus 2020; 57:282.

Valikodath N, Cole E, Chiang MF et al. Imaging in Retinopathy of Prematurity. Asia Pac J Ophthalmol (Phila) 2019; 8:178-186.

Patel SN, Shi A, Wibbelsman TD et al. Ultra-widefield retinal imaging: an update on recent advances. Ther Adv Ophthalmol 2020; 12:2515841419899495.

Vinekar A, Rao SV, Murthy S et al. A Novel, Low-Cost, Wide-Field, Infant Retinal Camera, "Neo": Technical and Safety Report for the Use on Premature Infants. Transl Vis Sci Technol 2019; 8:2.

Lee AC, Maldonado RS, Sarin N et al. Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina 2011; 31:1470-1482.

Wintergerst MWM, Petrak M, Li JQ et al. Non-contact smartphone-based fundus imaging compared to conventional fundus imaging: a low-cost alternative for retinopathy of prematurity screening and documentation. Sci Rep 2019; 9:19711.

Hellstrom A, Smith LE and Dammann O. Retinopathy of prematurity. Lancet 2013; 382:1445-1457.

Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008; 84:77-82.

Tsai AS, Chou HD, Ling XC et al. Assessment and management of retinopathy of prematurity in the era of anti-vascular endothelial growth factor (VEGF). Prog Retin Eye Res 2022; 88:101018.

Al-Khaled T, Valikodath NG, Patel SN et al. Addressing the Third Epidemic of Retinopathy of Prematurity Through Telemedicine and Technology: A Systematic Review. J Pediatr Ophthalmol Strabismus 2021; 58:261-269.

Hartnett ME. Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 2015; 122:200-210.

Chan-Ling T, Gole GA, Quinn GE et al. Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective. Prog Retin Eye Res 2018; 62:77-119.

Agarwal K and Jalali S. Classification of retinopathy of prematurity: from then till now. Community Eye Health 2018; 31:S4-S7.

Fierson WM, Ophthalmology AAOPSo, American Academy Of O et al. Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics 2018; 142.

Chen Y, Feng J, Li F et al. Analysis of Changes in Characteristics of Severe Retinopathy of Prematurity Patients after Screening Guidelines Were Issued in China. Retina 2015; 35:1674-1679.

Adeli M and Bloom WR. Implementing Telemedicine Visits in an Underserved Ophthalmology Clinic in the COVID-19 Era. J Prim Care Community Health 2021; 12:2150132721996278.

Weaver DT and Murdock TJ. Telemedicine detection of type 1 ROP in a distant neonatal intensive care unit. J AAPOS 2012; 16:229-233.

Wang SK, Callaway NF, Wallenstein MB et al. SUNDROP: six years of screening for retinopathy of prematurity with telemedicine. Can J Ophthalmol 2015; 50:101-106.

Campbell JP, Ryan MC, Lore E et al. Diagnostic Discrepancies in Retinopathy of Prematurity Classification. Ophthalmology 2016; 123:1795-1801.

Redd TK, Campbell JP, Brown JM et al. Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity. Br J Ophthalmol 2018.

Brown JM, Campbell JP, Beers A et al. Automated Diagnosis of Plus Disease in Retinopathy of Prematurity Using Deep Convolutional Neural Networks. JAMA Ophthalmol 2018; 136:803-810.

Palmer EA, Hardy RJ, Dobson V et al. 15-year outcomes following threshold retinopathy of prematurity: final results from the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol 2005; 123:311-318.

Palmer EA, Flynn JT, Hardy RJ et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology 1991; 98:1628-1640.

Hardy RJ, Good WV, Dobson V et al. Multicenter trial of early treatment for retinopathy of prematurity: study design. Control Clin Trials 2004; 25:311-325.

Good WV and Early Treatment for Retinopathy of Prematurity Cooperative G. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc 2004; 102:233-248; discussion 248-250.

Tasman W, Patz A, McNamara JA et al. Retinopathy of prematurity: the life of a lifetime disease. Am J Ophthalmol 2006; 141:167-174.

Sankar MJ, Sankar J and Chandra P. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity. Cochrane Database Syst Rev 2018; 1:CD009734.

Mintz-Hittner HA. Retinopathy of Prematurity: Intravitreal injections of bevacizumab: timing, technique, and outcomes. J AAPOS 2016; 20:478-480.

Mintz-Hittner HA, Kennedy KA, Chuang AZ et al. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011; 364:603-615.

Stahl A, Lepore D, Fielder A et al. Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet 2019; 394:1551-1559.

Kaushal M, Razak A, Patel W et al. Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol 2021; 41:1225-1235.

Xu Y, Zhang Q, Kang X et al. Early vitreoretinal surgery on vascularly active stage 4 retinopathy of prematurity through the preoperative intravitreal bevacizumab injection. Acta Ophthalmol 2013; 91:e304-310.

Nudleman E, Muftuoglu IK, Gaber R et al. Glaucoma after Lens-Sparing Vitrectomy for Advanced Retinopathy of Prematurity. Ophthalmology 2018; 125:671-675.

Nudleman E, Robinson J, Rao P et al. Long-term outcomes on lens clarity after lens-sparing vitrectomy for retinopathy of prematurity. Ophthalmology 2015; 122:755-759.

Nelson LB. Telemedicine in Pediatric Ophthalmology. J Pediatr Ophthalmol Strabismus 2020; 57:282.

Valikodath N, Cole E, Chiang MF et al. Imaging in Retinopathy of Prematurity. Asia Pac J Ophthalmol (Phila) 2019; 8:178-186.

Patel SN, Shi A, Wibbelsman TD et al. Ultra-widefield retinal imaging: an update on recent advances. Ther Adv Ophthalmol 2020; 12:2515841419899495.

Vinekar A, Rao SV, Murthy S et al. A Novel, Low-Cost, Wide-Field, Infant Retinal Camera, "Neo": Technical and Safety Report for the Use on Premature Infants. Transl Vis Sci Technol 2019; 8:2.

Lee AC, Maldonado RS, Sarin N et al. Macular features from spectral-domain optical coherence tomography as an adjunct to indirect ophthalmoscopy in retinopathy of prematurity. Retina 2011; 31:1470-1482.

Wintergerst MWM, Petrak M, Li JQ et al. Non-contact smartphone-based fundus imaging compared to conventional fundus imaging: a low-cost alternative for retinopathy of prematurity screening and documentation. Sci Rep 2019; 9:19711.